Ketan Laud, MD
Ophthalmology · Massapequa, NYNPI 1114151537
Payments from drug & device makers
Across 678 payments — averaging $1064.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$349K
- Mallinckrodt Hospital Products Inc.$216K
- Astellas Pharma Global Development$74K
- Astellas Pharma US Inc$44K
- Genentech USA, Inc.$18K
- Bayer$9K
- plus $11K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 163 | $349,404 |
| Mallinckrodt Hospital Products Inc. | 149 | $216,481 |
| Astellas Pharma Global Development | 55 | $74,303 |
| Astellas Pharma US Inc | 51 | $43,829 |
| Genentech USA, Inc. | 45 | $18,469 |
| Bayer | 3 | $8,667 |
| ANI Pharmaceuticals, Inc. | 19 | $5,274 |
| Regeneron Healthcare Solutions, Inc. | 61 | $1,716 |
| AbbVie(2 entities) | 39 | $805 |
| Bausch & Lomb Americas Inc. | 14 | $455 |
| Mallinckrodt Enterprises LLC | 8 | $358 |
| Alimera Sciences, Inc. | 7 | $259 |
| Apellis Pharmaceuticals, Inc. | 7 | $229 |
| Aerie Pharmaceuticals, Inc. | 5 | $195 |
| Novartis | 7 | $190 |
| Eyepoint US, Inc. | 4 | $190 |
| Oculus Surgical Inc. | 2 | $183 |
| Dompe US, Inc. | 2 | $157 |
| Harrow Eye, LLC | 4 | $121 |
| Sun Pharmaceutical Industries Inc. | 5 | $105 |
| Coherus Oncology, Inc. | 3 | $98 |
| Alcon | 5 | $93 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 5 | $92 |
| Oyster Point Pharma, Inc. | 3 | $80 |
| Kala Pharmaceuticals, Inc. | 4 | $80 |
| Amgen(2 entities) | 3 | $56 |
| Biotissue Holdings Inc. | 1 | $26 |
| Beaver-visitec International, Inc. | 1 | $23 |
| Shire North American Group Inc | 1 | $19 |
| Thea Pharma Inc. | 1 | $17 |
| Eyevance Pharmaceuticals LLC | 1 | $14 |
How this compares
$721,988 in reported general payments places this provider in the 95th percentile of 1,587 ophthalmology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Massapequa
- Eric SiglerMassapequa$484K
- Douglas JabsNew York$24.3M
- David RubaltelliBrooklyn$8.9M
- Philip FerroneGreat Neck$5.8M
- Eric DonnenfeldGarden City$2.6M
- Nathan RadcliffeNew York$2.4M
- Glenn StollerRockville Centre$2.1M
- Richard SpaideNew York$1.7M
- Paul HartmanRochester$1.6M
- Jason SlakterNew York$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.